Bladder cancer detection and monitoring: Assessment of urine- and blood-based marker tests

Steve Goodison, Charles J. Rosser, Virginia Urquidi

Research output: Contribution to journalReview article

69 Scopus citations

Abstract

Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.

Original languageEnglish (US)
Pages (from-to)71-84
Number of pages14
JournalMolecular Diagnosis and Therapy
Volume17
Issue number2
DOIs
StatePublished - Apr 1 2013

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Fingerprint Dive into the research topics of 'Bladder cancer detection and monitoring: Assessment of urine- and blood-based marker tests'. Together they form a unique fingerprint.

  • Cite this